ReviewGalen medical journal2025

Daratumumab Versus Control Treatment: A Systematic Review and Meta-analysis Study of Survival Outcomes Among Multiple Myeloma Patients : Survival Outcomes of Multiple Myeloma Treatment with Daratumumab.

Pouria Salajegheh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.